PharmAla Biotech Holdings Inc. (“PharmAla ” or the “Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel ...

The Toronto-Dominion Bank ("TD" or the "Bank") today announced a domestic public offering of C$1 billion of medium term notes (non-viability contingent capital (NVCC)) constituting subordinated ...

The results suggest the drug boasts similar safety and efficacy in non-small cell lung cancer compared with the field’s ...

Abington Heights Clarks Summit Elementary School third grader Knox Schweyer is competing in Colossal’s America’s Favorite ...

Mulvihill Capital Management Inc. (the "Manager"), the manager of Premium Income Corporation (the "Fund") is pleased to announce that at a special meeting of the holders of class A shares and ...

Kyverna Therapeutics has unveiled the full results from its registrational trial of miv-cel in stiff person syndrome (SPS), ...

For many popular exams, recent score reports reflect not a surge in student mastery, but a quiet lowering of the bar.

An investigational cocktail was tied to a 0% overall response rate in patients with gastroesophageal cancer, but developers ...

Kamehameha’s Kalei Harbottle has put in the time to become one of the state’s best throwers in the shot put and discus. “It was the same flow state that I had at Kamehameha. Just go easy, 70, 60%. My ...

Kyverna Therapeutics reported robust early Phase 2 miv-cel data in gMG, showing 100% response rates and deep, durable ...

SNiP Nutrigenomics analyzes 103 genetic markers to create custom supplement formulas, replacing guesswork with DNA-driven ...